A groundbreaking study has identified how previously mysterious mutations in non-coding DNA contribute to kidney disease, paving the way for new treatments. Researchers analyzed genetic data from 2.2 million people, pinpointing over 1,000 genome locations tied to kidney function.
Led by scientists from the University of Pennsylvania and the University of Rochester, the study mapped how non-coding DNA mutations influence gene expression, creating a “Kidney Disease Genetic Scorecard.” This discovery helps identify key disease-causing genes and potential drug targets.
Experts say the findings not only advance kidney disease research but could also apply to other diseases, unlocking new therapeutic possibilities through deeper genetic understanding.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].